{
  "DOI": "10.1186/s40246-024-00574-z",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-024-00574-z",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eCommunity pharmacists must be well-equipped to advance pharmacogenomics services. Nevertheless, limited data is available regarding pharmacists' knowledge and attitudes toward pharmacogenomics testing. The present study aimed to evaluate community pharmacists' knowledge and attitudes toward pharmacogenomics testing in the UAE.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eIn this cross-sectional study, a validated, online, self-administered survey, was randomly distributed to community pharmacists across the United Arab Emirates (UAE).\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eThe participants demonstrated poor knowledge about pharmacogenomic testing (median score \u0026lt; 8). Having 10–29 (Adjusted odds ration [AOR]: 0.038; 95% CI: 0.01–0.146, \u003cjats:italic\u003ep\u003c/jats:italic\u003e = 0.001) and 30–49 (AOR: 0.097; 95% CI: 0.04–0.237, \u003cjats:italic\u003ep\u003c/jats:italic\u003e = 0.001) patients per day was associated with poorer knowledge. Also, receiving 10–29 (AOR: 0.046; 95% CI: 0.005–0.401, \u003cjats:italic\u003ep\u003c/jats:italic\u003e = 0.005), 30–49 (AOR: 0.025; 95% CI: 0.003–0.211, \u003cjats:italic\u003ep\u003c/jats:italic\u003e = 0.001), and \u0026gt; 50 (AOR: 0.049; 95% CI: 0.005–0.458, \u003cjats:italic\u003ep\u003c/jats:italic\u003e = 0.008) prescriptions decreased the odds of having good knowledge. Around half (43.9%) of the participants did not show a positive attitude toward pharmacogenomic testing (median score \u0026lt; 11). Having 30–49 patients per day (AOR: 5.351; 95% CI: 2.414–11.860, \u003cjats:italic\u003ep\u003c/jats:italic\u003e = 0.001) increased the odds of good knowledge while receiving 10–29 (AOR: 0.133; 95% CI: 0.056–0.315, \u003cjats:italic\u003ep\u003c/jats:italic\u003e = 0.001) and 30–49 (AOR: 0.111; 95% CI: 0.049–0.252, \u003cjats:italic\u003ep\u003c/jats:italic\u003e = 0.001) prescriptions a day were associated with decreased odds of positive attitude toward the pharmacogenomics testing.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eThe findings indicate a lack of knowledge and less-than-ideal attitudes among community pharmacists regarding pharmacogenomics testing. Enhanced efforts focused on educational initiatives and training activities related to pharmacogenomics testing is needed. Additionally, reducing workload can facilitate better knowledge acquisition and help mitigate unfavorable attitudes.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "574"
  ],
  "article-number": "8",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "5 October 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "22 January 2024"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "30 January 2024"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The survey included a statement informing the participants that completing the survey represents a consent to participate. The study received ethical approval from Al Ain University (Reference: COP/AREC/AD/41)."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Ramadan",
      "given": "Azza",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Jarab",
      "given": "Anan S.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Al Meslamani",
      "given": "Ahmad Z.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2024,
        1,
        30
      ]
    ],
    "date-time": "2024-01-30T12:02:04Z",
    "timestamp": 1706616124000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        1,
        30
      ]
    ],
    "date-time": "2024-01-30T12:02:10Z",
    "timestamp": 1706616130000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        1,
        31
      ]
    ],
    "date-time": "2024-01-31T00:47:31Z",
    "timestamp": 1706662051119
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2024,
        1,
        30
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2024,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            1,
            30
          ]
        ],
        "date-time": "2024-01-30T00:00:00Z",
        "timestamp": 1706572800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            1,
            30
          ]
        ],
        "date-time": "2024-01-30T00:00:00Z",
        "timestamp": 1706572800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-024-00574-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-024-00574-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-024-00574-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2024,
        1,
        30
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2024,
        1,
        30
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1183/13993003.00391-2017",
      "author": "IR Konig",
      "doi-asserted-by": "publisher",
      "first-page": "1700391",
      "issue": "4",
      "journal-title": "Eur Respir J",
      "key": "574_CR1",
      "unstructured": "Konig IR, Fuchs O, Hansen G, von Mutius E, Kopp MV. What is precision medicine? Eur Respir J. 2017;50(4):1700391.",
      "volume": "50",
      "year": "2017"
    },
    {
      "author": "JT Oates",
      "first-page": "111",
      "issue": "2",
      "journal-title": "Int J Biomed Investig.",
      "key": "574_CR2",
      "unstructured": "Oates JT, Lopez D. Pharmacogenetics: an important part of drug development with a focus on its application. Int J Biomed Investig. 2018;1(2):111.",
      "volume": "1",
      "year": "2018"
    },
    {
      "author": "DJ Belle",
      "first-page": "1553",
      "issue": "11",
      "journal-title": "Am Fam Physician",
      "key": "574_CR3",
      "unstructured": "Belle DJ, Singh H. Genetic factors in drug metabolism. Am Fam Physician. 2008;77(11):1553–60.",
      "volume": "77",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.neulet.2018.09.018",
      "author": "R Cacabelos",
      "doi-asserted-by": "publisher",
      "journal-title": "Neurosci Lett",
      "key": "574_CR4",
      "unstructured": "Cacabelos R. Pharmacogenomics of Alzheimer’s and Parkinson’s diseases. Neurosci Lett. 2020;726: 133807.",
      "volume": "726",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12888-023-04756-2",
      "author": "X Wang",
      "doi-asserted-by": "publisher",
      "first-page": "334",
      "issue": "1",
      "journal-title": "BMC Psychiatry",
      "key": "574_CR5",
      "unstructured": "Wang X, Wang C, Zhang Y, An Z. Effect of pharmacogenomics testing guiding on clinical outcomes in major depressive disorder: a systematic review and meta-analysis of RCT. BMC Psychiatry. 2023;23(1):334.",
      "volume": "23",
      "year": "2023"
    },
    {
      "DOI": "10.1186/s12913-022-07730-y",
      "author": "T Rendell",
      "doi-asserted-by": "publisher",
      "first-page": "378",
      "issue": "1",
      "journal-title": "BMC Health Serv Res",
      "key": "574_CR6",
      "unstructured": "Rendell T, Barnett J, Wright D. Co-designing a community pharmacy pharmacogenomics testing service in the UK. BMC Health Serv Res. 2022;22(1):378.",
      "volume": "22",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.sapharm.2021.12.002",
      "author": "JM Hansen",
      "doi-asserted-by": "publisher",
      "first-page": "3230",
      "issue": "8",
      "journal-title": "Res Social Adm Pharm",
      "key": "574_CR7",
      "unstructured": "Hansen JM, Norgaard J, Kalvemark SS. A systematic review of pharmacogenetic testing in primary care: attitudes of patients, general practitioners, and pharmacists. Res Social Adm Pharm. 2022;18(8):3230–8.",
      "volume": "18",
      "year": "2022"
    },
    {
      "DOI": "10.5530/jyp.2015.3.3",
      "author": "AAAA Yau",
      "doi-asserted-by": "publisher",
      "first-page": "145",
      "issue": "3",
      "journal-title": "J Young Pharm",
      "key": "574_CR8",
      "unstructured": "Yau AAAA, Haque M. Knowledge, attitude and practice concerning pharmacogenomics among pharmacists: a systematic review. J Young Pharm. 2015;7(3):145–54.",
      "volume": "7",
      "year": "2015"
    },
    {
      "DOI": "10.1002/humu.21232",
      "author": "L Al-Gazali",
      "doi-asserted-by": "publisher",
      "first-page": "505",
      "issue": "5",
      "journal-title": "Hum Mutat",
      "key": "574_CR9",
      "unstructured": "Al-Gazali L, Ali BR. Mutations of a country: a mutation review of single gene disorders in the United Arab Emirates (UAE). Hum Mutat. 2010;31(5):505–20.",
      "volume": "31",
      "year": "2010"
    },
    {
      "DOI": "10.3389/fgene.2023.1177204",
      "author": "S Bizzari",
      "doi-asserted-by": "publisher",
      "first-page": "1177204",
      "journal-title": "Front Genet",
      "key": "574_CR10",
      "unstructured": "Bizzari S, Nair P, Hana S, Deepthi A, Al-Ali MT, Al-Gazali L, et al. Spectrum of genetic disorders and gene variants in the United Arab Emirates national population: insights from the CTGA database. Front Genet. 2023;14:1177204.",
      "volume": "14",
      "year": "2023"
    },
    {
      "DOI": "10.3390/jpm10040216",
      "author": "AT Rahma",
      "doi-asserted-by": "publisher",
      "first-page": "216",
      "issue": "4",
      "journal-title": "J Pers Med.",
      "key": "574_CR11",
      "unstructured": "Rahma AT, Elsheik M, Ali BR, Elbarazi I, Patrinos GP, Ahmed LA, et al. Knowledge, attitudes, and perceived barriers toward genetic testing and pharmacogenomics among healthcare workers in the united arab emirates: a cross-sectional study. J Pers Med. 2020;10(4):216.",
      "volume": "10",
      "year": "2020"
    },
    {
      "author": "S Muflih",
      "first-page": "655",
      "journal-title": "Pharmgenomics Pers Med",
      "key": "574_CR12",
      "unstructured": "Muflih S, Alshogran OY, Al-Azzam S, Al-Taani G, Khader YS. Physicians’ knowledge and attitudes regarding point-of-care pharmacogenetic testing: a hospital-based cross-sectional study. Pharmgenomics Pers Med. 2021;14:655–65.",
      "volume": "14",
      "year": "2021"
    },
    {
      "DOI": "10.3390/jpm10030134",
      "author": "AT rahma",
      "doi-asserted-by": "publisher",
      "first-page": "134",
      "issue": "3",
      "journal-title": "J Pers Med.",
      "key": "574_CR13",
      "unstructured": "rahma AT, elbarazi i, ali br, patrinos gp, ahmed la, al maskari f. genomics and pharmacogenomics knowledge, attitude and practice of pharmacists working in United Arab Emirates: findings from focus group discussions-a qualitative study. J Pers Med. 2020;10(3):134.",
      "volume": "10",
      "year": "2020"
    },
    {
      "author": "Z Alrabiah",
      "first-page": "433",
      "journal-title": "Pharmgenomics Pers Med",
      "key": "574_CR14",
      "unstructured": "Alrabiah Z, Syed W, Babelghaith SD, Al Arifi MN. Clinical knowledge, attitude, and perceptions of community pharmacists toward pharmacogenomics - a cross-sectional study from Saudi Arabia. Pharmgenomics Pers Med. 2023;16:433–41.",
      "volume": "16",
      "year": "2023"
    },
    {
      "DOI": "10.2217/pme.11.87",
      "author": "MW Roederer",
      "doi-asserted-by": "publisher",
      "first-page": "19",
      "issue": "1",
      "journal-title": "Per Med",
      "key": "574_CR15",
      "unstructured": "Roederer MW, Van Riper M, Valgus J, Knafl G, McLeod H. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing. Per Med. 2012;9(1):19–27.",
      "volume": "9",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.jsps.2020.12.006",
      "author": "AM Bagher",
      "doi-asserted-by": "publisher",
      "first-page": "53",
      "issue": "1",
      "journal-title": "Saudi Pharm J",
      "key": "574_CR16",
      "unstructured": "Bagher AM, Neamatallah T, Balto G, Almikhy L, Almutairi SS, Abushal MO, et al. Knowledge, perception, and confidence of hospital pharmacists toward pharmacogenetics in Jeddah, Kingdom of Saudi Arabia. Saudi Pharm J. 2021;29(1):53–8.",
      "volume": "29",
      "year": "2021"
    },
    {
      "DOI": "10.9734/jpri/2020/v32i1630741",
      "author": "NJ Ahmed",
      "doi-asserted-by": "publisher",
      "first-page": "177",
      "issue": "16",
      "journal-title": "J Pharm Res Int",
      "key": "574_CR17",
      "unstructured": "Ahmed NJ, Alrawili AS, Alkhawaja FZ. Knowledge and awareness on personalized medicine amongst health care specialists and university students in health colleges in Saudi Arabia. J Pharm Res Int. 2020;32(16):177–83.",
      "volume": "32",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12913-021-07040-9",
      "author": "L Albitar",
      "doi-asserted-by": "publisher",
      "first-page": "1031",
      "issue": "1",
      "journal-title": "BMC Health Serv Res",
      "key": "574_CR18",
      "unstructured": "Albitar L, Alchamat GA. Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians. BMC Health Serv Res. 2021;21(1):1031.",
      "volume": "21",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s40545-022-00435-x",
      "author": "U Abubakar",
      "doi-asserted-by": "publisher",
      "first-page": "39",
      "issue": "1",
      "journal-title": "J Pharm Policy Pract",
      "key": "574_CR19",
      "unstructured": "Abubakar U, Subramaniam L, Ayinla A, Ambali MN, Mohamed Noor DA, Daud NAA, et al. Knowledge, attitude and perception of community pharmacists toward pharmacogenomics services in northern Nigeria: a cross-sectional study. J Pharm Policy Pract. 2022;15(1):39.",
      "volume": "15",
      "year": "2022"
    },
    {
      "DOI": "10.18549/PharmPract.2019.3.1518",
      "author": "U Athiyah",
      "doi-asserted-by": "publisher",
      "first-page": "1518",
      "issue": "3",
      "journal-title": "Pharm Pract (Granada)",
      "key": "574_CR20",
      "unstructured": "Athiyah U, Setiawan CD, Nugraheni G, Zairina E, Utami W, Hermansyah A. Assessment of pharmacists’ knowledge, attitude and practice in chain community pharmacies toward their current function and performance in Indonesia. Pharm Pract (Granada). 2019;17(3):1518.",
      "volume": "17",
      "year": "2019"
    },
    {
      "DOI": "10.1111/ijcp.14435",
      "author": "Y Jarrar",
      "doi-asserted-by": "publisher",
      "issue": "9",
      "journal-title": "Int J Clin Pract",
      "key": "574_CR21",
      "unstructured": "Jarrar Y, Musleh R, Ghanim M, AbuKhader I, Jarrar Q. Assessment of the need for pharmacogenomics education among pharmacists in the West Bank of Palestine. Int J Clin Pract. 2021;75(9): e14435.",
      "volume": "75",
      "year": "2021"
    },
    {
      "DOI": "10.1371/journal.pone.0203033",
      "author": "A Albassam",
      "doi-asserted-by": "publisher",
      "issue": "9",
      "journal-title": "PLoS ONE",
      "key": "574_CR22",
      "unstructured": "Albassam A, Alshammari S, Ouda G, Koshy S, Awad A. Knowledge, perceptions and confidence of physicians and pharmacists toward pharmacogenetics practice in Kuwait. PLoS ONE. 2018;13(9): e0203033.",
      "volume": "13",
      "year": "2018"
    },
    {
      "DOI": "10.3390/ijerph191610073",
      "author": "ZA Alhaddad",
      "doi-asserted-by": "publisher",
      "first-page": "10073",
      "issue": "16",
      "journal-title": "Int J Environ Res Public Health",
      "key": "574_CR23",
      "unstructured": "Alhaddad ZA, AlMousa HA, Younis NS. Pharmacists’ Knowledge, and Insights in Implementing Pharmacogenomics in Saudi Arabia. Int J Environ Res Public Health. 2022;19(16):10073.",
      "volume": "19",
      "year": "2022"
    },
    {
      "author": "M Hayashi",
      "first-page": "409",
      "journal-title": "Pharmgenomics Pers Med",
      "key": "574_CR24",
      "unstructured": "Hayashi M, Mahmoud SH, Hamdy DA. The efficacy of a didactic and case-based pharmacogenomics education program on improving the knowledge and confidence of alberta pharmacists. Pharmgenomics Pers Med. 2022;15:409–27.",
      "volume": "15",
      "year": "2022"
    },
    {
      "DOI": "10.2217/pgs-2016-0002",
      "author": "SB Haga",
      "doi-asserted-by": "publisher",
      "first-page": "1491",
      "issue": "14",
      "journal-title": "Pharmacogenomics",
      "key": "574_CR25",
      "unstructured": "Haga SB, Mills R, Moaddeb J. Evaluation of a pharmacogenetic educational toolkit for community pharmacists. Pharmacogenomics. 2016;17(14):1491–502.",
      "volume": "17",
      "year": "2016"
    },
    {
      "key": "574_CR26",
      "unstructured": "Australasia RCoPo. 2018. Position Statement [Internet] Available from: https://www.rcpaeduau/Library/College-Policies/Position-Statements/Utilisation-of-pharmacogenetics-in-healthcare"
    },
    {
      "DOI": "10.1016/j.jsps.2020.05.008",
      "author": "H Aldosari",
      "doi-asserted-by": "publisher",
      "first-page": "803",
      "issue": "7",
      "journal-title": "Saudi Pharm J",
      "key": "574_CR27",
      "unstructured": "Aldosari H, Alsairafi Z, Waheedi S. Continuing education in pharmacy: A cross-sectional study exploring pharmacists’ attitudes and perceptions. Saudi Pharm J. 2020;28(7):803–13.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.4172/2161-0711.1000568",
      "author": "P Da",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "6",
      "journal-title": "J Commun Med Health Education.",
      "key": "574_CR28",
      "unstructured": "Da P, Sl N, Bp S, Ts K. Knowledge, awareness and attitude of pharmacists toward pharmacogenetic practice: perspective of community and hospital in Yogyakarta, Indonesia. J Commun Med Health Education. 2017;7(6):1–10.",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.1371/journal.pone.0231482",
      "author": "SC Shao",
      "doi-asserted-by": "publisher",
      "issue": "4",
      "journal-title": "PLoS ONE",
      "key": "574_CR29",
      "unstructured": "Shao SC, Chan YY, Lin SJ, Li CY, Kao Yang YH, Chen YH, et al. Workload of pharmacists and the performance of pharmacy services. PLoS ONE. 2020;15(4): e0231482.",
      "volume": "15",
      "year": "2020"
    },
    {
      "DOI": "10.2217/pgs-2019-0004",
      "author": "MP Frigon",
      "doi-asserted-by": "publisher",
      "first-page": "589",
      "issue": "8",
      "journal-title": "Pharmacogenomics",
      "key": "574_CR30",
      "unstructured": "Frigon MP, Blackburn ME, Dubois-Bouchard C, Gagnon AL, Tardif S, Tremblay K. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients. Pharmacogenomics. 2019;20(8):589–98.",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.2217/pme.15.57",
      "author": "JA Luzum",
      "doi-asserted-by": "publisher",
      "first-page": "119",
      "issue": "2",
      "journal-title": "Per Med",
      "key": "574_CR31",
      "unstructured": "Luzum JA, Luzum MJ. Physicians’ attitudes toward pharmacogenetic testing before and after pharmacogenetic education. Per Med. 2016;13(2):119–27.",
      "volume": "13",
      "year": "2016"
    },
    {
      "author": "SB Haga",
      "first-page": "877",
      "journal-title": "Pharmgenomics Pers Med",
      "key": "574_CR32",
      "unstructured": "Haga SB, Mills R, Moaddeb J, Liu Y, Voora D. Independent community pharmacists’ experience in offering pharmacogenetic testing. Pharmgenomics Pers Med. 2021;14:877–86.",
      "volume": "14",
      "year": "2021"
    },
    {
      "author": "DF Kisor",
      "first-page": "569",
      "journal-title": "Pharmgenomics Pers Med",
      "key": "574_CR33",
      "unstructured": "Kisor DF, Petry NJ, Bright DR. Pharmacogenomics in the United States community pharmacy setting: the Clopidogrel-CYP2C19 Example. Pharmgenomics Pers Med. 2021;14:569–77.",
      "volume": "14",
      "year": "2021"
    },
    {
      "DOI": "10.1097/FPC.0000000000000399",
      "author": "N Karuna",
      "doi-asserted-by": "publisher",
      "first-page": "73",
      "issue": "4",
      "journal-title": "Pharmacogenet Genomics",
      "key": "574_CR34",
      "unstructured": "Karuna N, Tragulpiankit P, Mahasirimongkol S, Chumnumwat S. Knowledge, attitude, and practice toward pharmacogenomics among hospital pharmacists in Thailand. Pharmacogenet Genomics. 2020;30(4):73–80.",
      "volume": "30",
      "year": "2020"
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-024-00574-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Investigation of community pharmacists’ knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "18"
}